Jessica Goldenberg

Jessica Goldenberg is currently serving as the Director Clinical Scientist at Cabaletta Bio since July 2024. Prior to this role, Jessica held positions as Associate Director, Clinical Scientist at Autifony Therapeutics and Adaptimmune from March 2022 to June 2024 and October 2020 to March 2022, respectively. Jessica's earlier experience includes Project Manager roles at Global Clinical Trials and ACI Clinical, as well as Clinical Lead at IQVIA. Additionally, Jessica worked as a Clinical Scientist at Inovio Pharmaceuticals Inc. and a Regional CRA at Quintiles, with a focus on Phase II-IV trials. Starting a career in the clinical field, Jessica was a Clinical Trial Specialist at PSI CRO AG and an In-House CRA at Neuromed- CombinatoRx. Jessica holds a Bachelor of Arts in Psychology with a concentration in Neural and Behavioral Sciences from Bryn Mawr College and a Master of Science in Regulatory Affairs and Quality Assurance from Temple University School of Pharmacy.